1. Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction.
- Author
-
Braun, Alice, Shekhar, Sudhanshu, Levey, Daniel, Straub, Peter, Kraft, Julia, Panagiotaropoulou, Georgia, Heilbron, Karl, Awasthi, Swapnil, Meleka Hanna, Rafael, Hoffmann, Sarah, Stein, Maike, Lehnerer, Sophie, Mergenthaler, Philipp, Elnahas, Abdelrahman, Topaloudi, Apostolia, Koromina, Maria, Palviainen, Teemu, Asbjornsdottir, Bergrun, Stefansson, Hreinn, Skuladóttir, Astros, Jónsdóttir, Ingileif, Stefansson, Kari, Reis, Kadri, Esko, Tõnu, Palotie, Aarno, Leypoldt, Frank, Stein, Murray, Fontanillas, Pierre, Kaprio, Jaakko, Gelernter, Joel, Davis, Lea, Paschou, Peristera, Tannemaat, Martijn, Verschuuren, Jan, Kuhlenbäumer, Gregor, Gregersen, Peter, Huijbers, Maartje, Stascheit, Frauke, Meisel, Andreas, and Ripke, Stephan
- Subjects
Humans ,Myasthenia Gravis ,Genome-Wide Association Study ,Multifactorial Inheritance ,Genetic Predisposition to Disease ,Polymorphism ,Single Nucleotide ,Age of Onset ,Male ,Female ,Middle Aged ,Case-Control Studies ,Genetic Loci ,Alleles ,White People ,Adult - Abstract
Myasthenia gravis (MG) is a rare autoantibody-mediated disease affecting the neuromuscular junction. We performed a genome-wide association study of 5708 MG cases and 432,028 controls of European ancestry and a replication study in 3989 cases and 226,643 controls provided by 23andMe Inc. We identified 12 independent genome-wide significant hits (P
- Published
- 2024